JaDeVin

JaDeVin Updated 

Upon false breakout (Hikkake) signal in 1h chart (not shown), I have loaded up my short position. Bullish momentum is still here, a bit risky. Outside Bar two candles ago (see red labeldown, ongoing upward trend and falling down out of the price channel make me confident that it will play out well. Stop Loss and target gain are shown (Reward/Risk ratio =1.1).

JaDeVin

Low volume , bullish momentum by the 3 Inside Up chart pattern reversed near the upper trend line . However, no clear bearish momentum while still in overall bear market. Wait for signal upwards or downwards

JaDeVin

Nice setup .. went short and trade is open. Yesterday i had to close my short position, but in this coppy market everything is possible. Sentiment is still bearish with a good reward/risk ratio down.

JaDeVin

Cypher Pattern is a trend continuation pattern, it is traded in the direction of overall trend when the price is approaching point D. We are just now back in the bear mode!

JaDeVin Updated 

Since bearish butterfly down trend has been active. Bullish reversal just happened, but lacked momentum upwards. I seize this opportunity to go short.

JaDeVin

Ultimate Oscillator: This is a range-bound indicator, which means the value fluctuates between 0 and 100. Similar to the RSI, levels below 30 are deemed to be oversold, and levels above 70 are deemed to be overbought. Transaction signals are derived by finding situations where the price is going in opposite directions than the indicator. Once this divergence has...

JaDeVin Updated 

No great price action upwards has happened since the latest market bottom. Now bounce back within the trend channel to the next support (78.6% retracement). Stay short! ***This information is not a recommendation to buy or sell. It is to be used for educational purposes only.***

JaDeVin Updated 

Likely there will be a price movement, I assume upwards.

JaDeVin

What a wonderful animal. Going batty! I am usually not a big fan of harmonic patterns (because of the ambiguity of XA line), but looks great.

JaDeVin

This is biotech "at its best". An expert review board gave this drug an approval of passing, with a shelf offering of about $100 millions. And now ... Sollpura has just failed to achieve the desired results in a Phase 3 clinical study ... Luckily, I closed one trade with a win for this stock. Conclusion: Stay away from small biotech firms!

JaDeVin Updated 

Tug of war between bulls and bears is ongoing. Situation has just become slighly in favor of the bulls, but be aware that bears are always drowsy before they strike back.

JaDeVin

Good opportunity here to see price movement. Lufthansa has dropped by -5.61% since the last trading day. The average target price for this stock calculated by the analysts is €31.10 (provided that market is in bull mode). Deutsche Lufthansa has a trailing twelve months PE ratio of 8.5 and P/CF is 4.5 (which is better than the industrial sector average)...

JaDeVin

Nike has been a sensational investment because it is phenomenal brand with high-quality products led by a skilled management team. However, it is not a moat-wide company, being under pressure and up against competition like ADIDAS. However, despite declining growth rates and margin prospects the stock has jumped from 52USD to 66USD. Based on the concept of...

JaDeVin

It is too early to switch sides. Trend channel is still active. I surmise that the strong bullish candle up to 9300 USD is likely a bull trap. We will see. Good luck! ***This information is not a recommendation to buy or sell. It is to be used for educational purposes only.***

JaDeVin Updated 

Duluth Holdings keeps scaling up, investors do no longer ignore it and buy in before earnings! Company's retail sales growth is soaring and solid gross margins will be maintained.

JaDeVin Updated 

Seems very bearish for me ... double top chart pattern/break of bullish chart channel

JaDeVin Updated 

12-month consensus price target 20$ - exceptional growth potential and undervalued, but stock suffers from class action lawsuit in terms of unethical business allegations that has been commenced.

JaDeVin Updated 

Sanofi shares have been plummeting because of lowering net income, disappointing return on equity and performance in the stock itself. However, market was overreacting and short-term bullish reversal ought to be considered.